Cargando…

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy

BACKGROUND: Antigen processing by dendritic cells (DC) exposed to specific stimuli has been well characterized in biological studies. Nonetheless, the question of whether autologous whole tumor lysates (as used in clinical trials) are similarly processed by these cells has not yet been resolved. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fiammenghi, Laura, Ancarani, Valentina, Rosales, Tilman, Knutson, Jay R, Petrini, Massimiliano, Granato, Anna Maria, Pancisi, Elena, Ridolfi, Laura, Ridolfi, Ruggero, Riccobon, Angela, Neyroz, Paolo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894751/ https://www.ncbi.nlm.nih.gov/pubmed/20525246 http://dx.doi.org/10.1186/1479-5876-8-52

Ejemplares similares

Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in patients with metastatic melanoma: a randomised “proof-of-principle” phase II study
por: de Rosa, Francesco, et al.
Publicado: (2014)

Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
por: Ridolfi, Laura, et al.
Publicado: (2018)

Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis
por: Ridolfi, Laura, et al.
Publicado: (2010)

Erratum to “Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis”
por: Ridolfi, Laura, et al.
Publicado: (2011)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
por: Ridolfi, Ruggero, et al.
Publicado: (2006)

Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients
por: Ridolfi, Laura, et al.
Publicado: (2013)

Evaluation of in vivo labelled dendritic cell migration in cancer patients
por: Ridolfi, Ruggero, et al.
Publicado: (2004)

Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
por: Bulgarelli, Jenny, et al.
Publicado: (2019)

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center
por: Pancisi, Elena, et al.
Publicado: (2022)

Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay
por: Carloni, Silvia, et al.
Publicado: (2021)

Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
por: Bulgarelli, Jenny, et al.
Publicado: (2021)

The Renewal of Cancer Immunotherapy
por: Bulgarelli, Jenny, et al.
Publicado: (2023)

The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study
por: Fea, Antonio M., et al.
Publicado: (2016)

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)

Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma
por: Parney, Ian F, et al.
Publicado: (2020)

Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2
por: De Paola, F, et al.
Publicado: (2003)

FRET Microscopy in Yeast
por: Skruzny, Michal, et al.
Publicado: (2019)

Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma
por: Parney, Ian F, et al.
Publicado: (2022)

Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
por: Pasqualetti, Francesco, et al.
Publicado: (2023)

Accelerated FRET-PAINT microscopy
por: Lee, Jongjin, et al.
Publicado: (2018)

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
por: Kandalaft, Lana E, et al.
Publicado: (2013)

CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro
por: Ghorbaninezhad, Farid, et al.
Publicado: (2022)

Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
por: Ridolfi, Laura, et al.
Publicado: (2014)

Autologous and Pooled Tumor Lysates in Combined Immunotherapy of Patients with Glioblastoma
por: Mishinov, S.V., et al.
Publicado: (2020)

A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
por: Matsushita, Hirokazu, et al.
Publicado: (2014)

Mesenchymal Stromal Stem Cell-Derived Microvesicles Enhance Tumor Lysate Pulsed Dendritic Cell Stimulated Autologous T lymphocyte Cytotoxicity
por: Kukia, Nasim Rahmani, et al.
Publicado: (2018)

Autologous cervical tumor lysate pulsed dendritic cell stimulation followed by cisplatin treatment abrogates FOXP3+ cells in vitro
por: Dhandapani, Hemavathi, et al.
Publicado: (2021)

Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy with Cytokine-Induced Killer Cells Improves Survival in Gastric and Colorectal Cancer Patients
por: Gao, Daiqing, et al.
Publicado: (2014)

Autologous platelet lysate local injections for the treatment of refractory lateral epicondylitis
por: Tan, Xun-xiang, et al.
Publicado: (2016)

Characteristics of Platelet Lysate Compared to Autologous and Allogeneic Serum Eye Drops
por: Zhang, Jie, et al.
Publicado: (2020)

Super Activated Platelet Lysate, a Novel Autologous Platelet Lysate, Regulates the Expression of Inflammasome and Cytokine in the Experimental Periodontitis in Rats
por: Zhang, Yi, et al.
Publicado: (2020)

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
por: Santin, A D, et al.
Publicado: (2002)

Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells
por: Roufarshbaf, Mohammad, et al.
Publicado: (2021)

Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
por: Belmans, Jochen, et al.
Publicado: (2017)

Human Platelet Lysate as an Alternative to Autologous Serum for Human Chondrocyte Clinical Use
por: Philippe, Virginie, et al.
Publicado: (2021)

Single-Pair FRET Microscopy Reveals Mononucleosome Dynamics
por: Koopmans, W. J. A., et al.
Publicado: (2007)

The protein architecture of the endocytic coat analyzed by FRET microscopy
por: Skruzny, Michal, et al.
Publicado: (2020)

Optimal inference of molecular interaction dynamics in FRET microscopy
por: Kamino, Keita, et al.
Publicado: (2023)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p3tnlbu98ig94fsnfanvdoplc9